Recombinant Factor C Validation—Simpler Than You Think!

References

1. 1.↵
   Council of Europe. Recombinant Factor C: New Ph. Eur. Chapter Available as of 1 July 2020. EDQM Web site. https://www.edqm.eu/en/news/recombinant-factor-c-new-ph-eur-chapter-available-1-july-2020 (accessed September 15, 2020).
2. 2.↵
   U.S. Pharmacopeial Convention, General Chapter <1225> Validation of Compendial Procedures. In USP 39—NF 34, USP: Rockville, MD, 2016; pp 1640–1645.
3. 3.↵
   U.S. Pharmacopeial Convention, General Chapter <85> Bacterial Endotoxins Test. In USP 39—NF 34, USP: Rockville, MD, 2016; pp 161–166.
4. 4.↵
   Microcoat Biotechnologie GmbH. Study for Validation of Recombinant Factor C Reagent (ENDOZYME® II GO) as Alternative Method Compared to Limulus Amebocyte Lysate, 2019.
5. 5.↵
   1. Muroi M.,
   2. Ogura N.,
   3. Mizumura H.,
   4. Aketagawa J.,
   5. Oda T.,
   6. Tanamoto K. I.

   Application of a Recombinant Three-Factor Chromogenic Reagent, PyroSmart, for Bacterial Endotoxins Test Filed in the Pharmacopeias. Biol. Pharm. Bull. 2019, 42 (12), 2024–2037.

   OpenUrl
6. 6.↵
   U.S. Food and Drug Administration, Guidance for Industry: Pyrogen and Endotoxins Testing: Questions and Answers. Center for Biologics Evaluation and Research. U.S. Department of Health and Human Services: Rockville, MD, 2012.
7. 7.↵
   Council of Europe, Guidelines for Using the Test for Bacterial Endotoxins, Chapter 5.1.10. In European Pharmacopoeia (Ph. Eur.), Suppl 8.8, Council of Europe: Strasbourg, France, 2016; pp 5931–5934.
8. 8.↵
   International Council for Harmonisation, Harmonised Tripartite Guideline Q2(R1): Validation of Analytical Procedures, ICH: Geneva, 2005.
9. 9.↵
   1. Loverock B.,
   2. Simon B.,
   3. Burgenson A.,
   4. Baines A. I.

   A Recombinant Factor C Procedure for the Detection of Gram-Negative Bacterial Endotoxin. The United States Pharmacopeial Convention, Stimuli to the Revision Process. Pharmacopeial Forum 2009, 35 (6), 1613–1621.

   OpenUrl
10. 10.↵
    1. Bolden J.,
    2. Smith K.

    Application of Recombinant Factor C Reagent for the Detection of Bacterial Endotoxins in Pharmaceutical Products. PDA J. Pharm. Sci. Technol. 2017, 71 (5), 405–412.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Kikuchi Y.,
    2. Haishima Y.,
    3. Fukui C.,
    4. Murai T.,
    5. Nakagawa Y.,
    6. Ebisawa A.,
    7. Matsumura K.,
    8. Ouchi K.,
    9. Oda T.,
    10. Mukai M.,
    11. Masuda T.,
    12. Katto Y.,
    13. Takasuga Y.,
    14. Takaoka A.

    Collaborative Study on the Bacterial Endotoxins Test Using Recombinant Factor C-Based Procedure for Detection of Lipopolysaccharides. Pharm. Med. Device Regul. Sci. 2017, 48 (4), 252–260.

    OpenUrl
12. 12.↵
    1. Kikuchi Y.,
    2. Haishima Y.,
    3. Fukui C.,
    4. Nakagawa Y.,
    5. Ebisawa A.,
    6. Morioka T.,
    7. Matsumura K.,
    8. Ouchi K.,
    9. Uchida K.,
    10. Martinez O.,
    11. Oda T.,
    12. Mukai M.,
    13. Masuda T.,
    14. Tsukihashi Y.,
    15. Takasuga Y.,
    16. Takaoka A.

    Collaborative Study on the Bacterial Endotoxins Test Using Recombinant Factor C-Based Procedure for Detection of Lipopolysaccharides, Part 2. Pharm. Med. Device Regul. Sci. 2018, 49 (10), 708–719.

    OpenUrl
13. 13.↵
    1. Bolden J.,
    2. Knutsen C.,
    3. Levin J.,
    4. Milne C.,
    5. Morris T.,
    6. Mozier N.,
    7. Spreitzer I.,
    8. von Wintzingerode F.

    Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable for the Detection of Environmental Bacterial Endotoxins? A Review. PDA J. Pharm. Sci. Technol. 2020, 74 (5), 602–611.

    OpenUrlAbstract/FREE Full Text